As a paradigm-shifting concept in radiobiology, low-dose radiation preconditioning (LDRP) describes a phenomenon wherein prior low-dose exposure engenders resistance to subsequent high-dose challenges. Although this adaptive response has been observed across diverse biological systems, its mechanistic basis, determinants of inter-individual variability, and clinical translatability remain under active investigation. This narrative review synthesizes the available evidence on LDRP, critically appraising current knowledge across three interconnected domains: (1) the molecular architecture of the adaptive response; (2) translational barriers, with emphasis on dose/dose-rate optimization, temporal intervals, and predictive biomarkers for radiotherapy; and (3) future avenues toward personalized LDRP in precision oncology. By integrating radiobiological and preclinical findings, this review offers a comprehensive framework for bench-to-bedside translation. Achieving personalized low-dose radiation strategies will hinge upon interdisciplinary collaboration, prospective validation, and the assimilation of multi-omics data into predictive algorithms— three interconnected domains that will chart the course for this emerging field.
No takes yet. Share an insight, caveat, or question.
Tong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: